The Venture Codex Logo

The Venture Codex

Overview

Venture capital firm financing early and mid-stage life science companies.

Founded

2008

Deals · 12mo

4

Stage focus

Series A
Series B
Series C

Geographic focus

Denmark
France
Spain
Switzerland
...

Sector focus

Asset Management
Finance
Financial Services

Investment portfolio

67rounds
NAMEDATESIZE
Anaconda BioMed
Sep 2026Participated
$56 MOther Equity
Kynexis
Aug 2026Participated
$46 MSeries A
Ona Therapeutics
Jun 2026Participated
$87 MSeries B
ADCendo
Apr 2026Participated
$76 MSeries C
Splice Bio
Jun 2025Participated
$135 MSeries B
ReproNovo
May 2025Participated
$65 MSeries A
ADCendo
Nov 2024Participated
$135 MSeries B
ADCendo
May 2024Participated
$17 MSeries A
Memo Therapeutics
May 2024Participated
$22 MSeries C
Engrail Therapeutics
Mar 2024Participated
$157 MSeries B
Neurona Therapeutics
Feb 2024Participated
$120 MOther Equity
Kynexis
Nov 2023Participated
$61 MSeries A
Anaconda BioMed
Sep 2026Participated
$56 MOther Equity
Kynexis
Aug 2026Participated
$46 MSeries A
Ona Therapeutics
Jun 2026Participated
$87 MSeries B
ADCendo
Apr 2026Participated
$76 MSeries C
Splice Bio
Jun 2025Participated
$135 MSeries B
ReproNovo
May 2025Participated
$65 MSeries A
ADCendo
Nov 2024Participated
$135 MSeries B
ADCendo
May 2024Participated
$17 MSeries A
Memo Therapeutics
May 2024Participated
$22 MSeries C
Engrail Therapeutics
Mar 2024Participated
$157 MSeries B
Neurona Therapeutics
Feb 2024Participated
$120 MOther Equity
Kynexis
Nov 2023Participated
$61 MSeries A
67
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ysios Capital: 67 funding rounds are recorded in the selected participation categories.All available history.
Ysios Capital: 67 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A89
Series B315
Series C+413
Other Equity312

Monthly Deal Activity

Ysios Capital: 67 deals are recorded across 206 months.All available history.
Ysios Capital: 67 deals are recorded across 206 months. All available history
MonthDeals
Sep '091
Oct '090
Nov '090
Dec '090
Jan '100
Feb '100
Mar '100
Apr '100
May '100
Jun '100
Jul '100
Aug '100
Sep '101
Oct '100
Nov '100
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '111
Jul '110
Aug '110
Sep '111
Oct '110
Nov '110
Dec '111
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '121
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '131
Jun '130
Jul '130
Aug '130
Sep '130
Oct '131
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '141
May '140
Jun '140
Jul '140
Aug '140
Sep '141
Oct '140
Nov '140
Dec '140
Jan '150
Feb '151
Mar '151
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '151
Oct '151
Nov '150
Dec '150
Jan '161
Feb '160
Mar '161
Apr '161
May '160
Jun '160
Jul '160
Aug '160
Sep '161
Oct '160
Nov '162
Dec '160
Jan '170
Feb '171
Mar '172
Apr '170
May '172
Jun '171
Jul '170
Aug '170
Sep '170
Oct '170
Nov '171
Dec '171
Jan '180
Feb '180
Mar '180
Apr '180
May '181
Jun '180
Jul '180
Aug '180
Sep '181
Oct '181
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '191
May '190
Jun '191
Jul '191
Aug '190
Sep '191
Oct '190
Nov '190
Dec '191
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '201
Jul '201
Aug '200
Sep '202
Oct '201
Nov '200
Dec '200
Jan '211
Feb '210
Mar '211
Apr '211
May '211
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '211
Jan '220
Feb '221
Mar '220
Apr '220
May '221
Jun '221
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '231
May '231
Jun '231
Jul '230
Aug '231
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '241
Mar '241
Apr '240
May '242
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '251
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '261
Jul '260
Aug '261
Sep '261
Oct '260

Sector Breakdown

Ysios Capital: Health & Life Sciences is the largest displayed sector by deal count (67 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ysios Capital: Health & Life Sciences is the largest displayed sector by deal count (67 deals). All available history
SectorDeals
Health & Life Sciences67
Manufacturing4
Enterprise Software3
Hardware & Robotics2
Developer Tools2
Networks, Cloud & Communication1

Deal Size Distribution

Ysios Capital: 67 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ysios Capital: 67 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M5
$5M-$10M4
$10M-$25M14
$25M-$50M19
$50M-$100M19
$100M-$250M6
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Ysios Capital: Europe has the largest recorded deal count among the displayed regions (54 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Ysios Capital: Europe has the largest recorded deal count among the displayed regions (54 deals). All available history
RegionDeals
Europe54
United States13
Ysios Capital: 20 co-investors are shown, with Gilde Healthcare sharing 14 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Ysios Capital: Led accounts for 27% and participating for 73% of round participation.All available history.
Ysios Capital: Led accounts for 27% and participating for 73% of round participation. All available history
CategoryDeals (count)Share (%)
Led1827%
Participating4973%
Ysios Capital: Single-lead accounts for 39% and co-led for 61% of lead dynamics.All available history.
Ysios Capital: Single-lead accounts for 39% and co-led for 61% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead739%
Co-led1161%

Team

Claudia D’Augusta

Venture Partner

Cristina Garmendia

Founding Partner and Member of the Board

Joel Jean Mairet

Managing Partner and Co - Founder

Karen Wagner

General Partner

Lance Berman

Venture Partner

Miriam Cortés

Executive Assistant & Corporate Communications, Office manager